COMPOSITION PHARMACEUTIQUE CONTENANT UN DÉRIVÉ DE FK506 DESTINÉE À TRAITER UNE INFECTION FONGIQUE PROVOQUÉE PAR LE GENRE CRYPTOCOCCUS ET LE GENRE CANDIDA ET UTILISATION ASSOCIÉE

• 收藏
• 分享

专利权人:

Intron Biotechnology Co. Ltd.

发明人:

申请号：

EP15814564.9

公开号：

EP3162369A4

申请日:

2015.06.29

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to a pharmaceutical composition containing FK506 derivative for treating a fungal infection caused by the genus Cryptococcus or the genus Candida, and a use thereof. In addition, the present invention relates to a therapeutic agent for fungal infection caused by the genus Cryptococcus or the genus Candida, the therapeutic agent containing FK506 derivative. The pharmaceutical composition of the present invention is harmless to the human body, and can make a great contribution to providing antifungal drugs with an excellent antifungal effect.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/